707 related articles for article (PubMed ID: 11230319)
1. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
2. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
Fedorova OV; Lakatta EG; Bagrov AY
Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
[TBL] [Abstract][Full Text] [Related]
3. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
[TBL] [Abstract][Full Text] [Related]
4. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
[TBL] [Abstract][Full Text] [Related]
5. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
6. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
[TBL] [Abstract][Full Text] [Related]
7. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
[TBL] [Abstract][Full Text] [Related]
8. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
9. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
J Hypertens; 2004 Feb; 22(2):389-97. PubMed ID: 15076199
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
Fedorova OV; Bagrov AY
Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
[TBL] [Abstract][Full Text] [Related]
12. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular Na,K-ATPase activity in salt induced hypertension in Dahl rats.
Vasdev S; Prabhakaran VM; Fernandez P; Sampson C
Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):79-91. PubMed ID: 2849788
[TBL] [Abstract][Full Text] [Related]
14. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
Fedorova OV; Dorofeeva NA; Lopatin DA; Lakatta EG; Bagrov AY
Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
[TBL] [Abstract][Full Text] [Related]
15. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
[TBL] [Abstract][Full Text] [Related]
16. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells.
Periyasamy SM; Liu J; Tanta F; Kabak B; Wakefield B; Malhotra D; Kennedy DJ; Nadoor A; Fedorova OV; Gunning W; Xie Z; Bagrov AY; Shapiro JI
Kidney Int; 2005 May; 67(5):1868-77. PubMed ID: 15840034
[TBL] [Abstract][Full Text] [Related]
17. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
18. Dietary sodium and Na,K-ATPase activity in Dahl salt-sensitive versus salt-resistant rats.
Abdelrahman AM; Harmsen E; Leenen FH
J Hypertens; 1995 May; 13(5):517-22. PubMed ID: 7561008
[TBL] [Abstract][Full Text] [Related]
19. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY
J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690
[TBL] [Abstract][Full Text] [Related]
20. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
Bagrov AY; Fedorova OV; Austin-Lane JL; Dmitrieva RI; Anderson DE
Hypertension; 1995 Nov; 26(5):781-8. PubMed ID: 7591018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
